UniProtKB/SwissProt variant VAR

Variant information

Variant position:

852

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:

LP/P [Disclaimer]

The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Methionine (M) to Valine (V) at position 852 (M852V, p.Met852Val).

Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:

Similar physico-chemical property. Both residues are medium size and hydrophobic.

The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:

1

The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page

Variant description:

In HLD7.

Any additional useful information about the variant.

Other resources:

Links to websites of interest for the variant.

Variant rs267608671 [ dbSNP | Ensembl ]

Sequence information

Variant position:

852

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:

1390

The length of the canonical sequence.

Location on the sequence:

GFVANSFYSGLTPTEFFFHT M AGREGLVDTAVKTAETGYMQ

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         GFVANSFYSGLTPTEFFFHTMAGREGLVDTAVKTAETGYMQ

Bovine                        GFVANSFYSGLTPTEFFFHTMAGREGLVDTAVKTAETGYMQ

Chicken                       GFVANSFYSGLTPTEFFFHTMAGREGLVDTAVKTAETGYMQ

Slime mold                    GFVSNSFYTGMIPTEFFFHTMGGREGLVDTAVKTAETGYMQ

Baker's yeast                 GFVRNSFFSGLSPPEFLFHAISGREGLVDTAVKTAETGYMS

Fission yeast                 GFVSNSFYSGLTPTEFLFHAISGREGLVDTAVKTAETGYMS

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 1390	DNA-directed RNA polymerase III subunit RPC1
Region	844 – 856	Bridging helix
Helix	844 – 879

Literature citations

Mutations of POLR3A encoding a catalytic subunit of RNA polymerase Pol III cause a recessive hypomyelinating leukodystrophy.
Bernard G.; Chouery E.; Putorti M.L.; Tetreault M.; Takanohashi A.; Carosso G.; Clement I.; Boespflug-Tanguy O.; Rodriguez D.; Delague V.; Abou Ghoch J.; Jalkh N.; Dorboz I.; Fribourg S.; Teichmann M.; Megarbane A.; Schiffmann R.; Vanderver A.; Brais B.;
Am. J. Hum. Genet. 89:415-423(2011)
Cited for: VARIANTS HLD7 ASN-372; LEU-558; TYR-636; GLU-672; TYR-724; ILE-775; VAL-852 AND THR-1247 INS; INVOLVEMENT IN HLD7; TISSUE SPECIFICITY;

Mutations in POLR3A and POLR3B are a major cause of hypomyelinating leukodystrophies with or without dental abnormalities and/or hypogonadotropic hypogonadism.
Daoud H.; Tetreault M.; Gibson W.; Guerrero K.; Cohen A.; Gburek-Augustat J.; Synofzik M.; Brais B.; Stevens C.A.; Sanchez-Carpintero R.; Goizet C.; Naidu S.; Vanderver A.; Bernard G.;
J. Med. Genet. 50:194-197(2013)
Cited for: VARIANTS HLD7 LEU-91; GLY-387; ARG-602; VAL-852; CYS-1005 AND LYS-1261;

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot O14802: Variant p.Met852Val